Comparison of cellulose diacetate and polysulfone membranes in the outcome of acute renal failure. A prospective randomized study

Nephrology Dialysis Transplantation

Volumn 15, Issue 2, 2000, Pages 224-230

  Gastaldello, Karine ^a   Vanherweghem, Jean Louis ^a   Tielemans, Christian ^a   Melot, Christian ^a   Kahn, Robert Jean ^a   Vincent, Jean Louis ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

Acute renal failure; Biocompatibility; Dialysis membrane; Haemodialysis; Sepsis; Survival

Indexed keywords

CELLULOSE ACETATE; CELLULOSE DERIVATIVE; CELLULOSE DIACETATE; POLYSULFONE; UNCLASSIFIED DRUG;

ACUTE KIDNEY FAILURE; ADULT; ARTICLE; BIOCOMPATIBILITY; CLINICAL TRIAL; COMPLEMENT ACTIVATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; COST; CREATININE CLEARANCE; DIALYSIS MEMBRANE; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MEMBRANE PERMEABILITY; MULTIVARIATE ANALYSIS; OLIGURIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TREATMENT OUTCOME;

BIOCOMPATIBLE MATERIALS; CELLULOSE; FEMALE; HUMANS; KIDNEY FAILURE, ACUTE; MALE; MEMBRANES, ARTIFICIAL; MIDDLE AGED; POLYMERS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RENAL DIALYSIS; SEVERITY OF ILLNESS INDEX; SULFONES; SURVIVAL ANALYSIS;

EID: 0033955875     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/15.2.224     Document Type: Article

References (33)

1. Chew SL, Lins RL, Daelemans R, De Broe ME. Outcome in acute renal failure. Nephrol Dial Transplant 1993; 8: 101-107
2. Pascual M, Swinford RD, Tolkoff-Rubin N. Acute renal failure: role of dialysis membrane biocompatibility. Annu Rev Med 1997; 48: 467-476
3. Hakim RM, Wingard RL, Parker RA. Effect of the dialysis membrane in the treatment of patients with acute renal failure. N Engl J Med 1994; 331: 1338-1342
4. Schiffl H, Lang SM, König A, Strasser T, Haider MC, Held E. Biocompatible membranes in acute renal failure: prospective case-controlled study. Lancet 1994; 344: 570-572
5. Kurtal H, von Herrath D, Schaefer K. Is the choice of membrane important for patients with acute renal failure requiring hemodialysis? Artif Organs 1995; 19: 391-394
6. Himmelfarb J, Tolkoff NR, Chandran P, Parker RA, Wingard RL, Hakim R. A multicenter comparison of dialysis membranes in the treatment of acute renal failure requiring dialysis. J Am Soc Nephrol 1998; 9: 257-266
7. Damiano AM, Bergner M, Draper EA, Knaus WA, Wagner DP. Reliability of measure of severity of illness: acute physiology of chronic health evaluation-II. J Clin Epidemiol 1992; 45: 93-101
8. Klinkmann H, Vienken J. Membranes for dialysis. Nephrol Dial Transplant 1995; 10 [Suppl. 3]: 39-45
9. Knaus WA, Wagner DP, Draper EA et al. The APACHE III prognostic system: Risk prediction of hospital mortality for critically ill hospitalized adults. Chest 1991; 100: 1619-1636
10. Douma CE, Redekop WK, Van der Meulen JHP et al. Predicting mortality in intensive care patients with acute renal failure treated with dialysis. J Am Soc Nephrol 1997; 8: 111-117
11. Parker RA, Himmelfarb J, Tolkoff-Rubin N. Chandran P, Wingard RL, Hakim RM. Prognosis of patients with acute renal failure requiring hemodialysis: results of a multicenter study. Am J Kidney Dis 1998; 32: 432-443
12. Maher ER, Robinson KN, Scoble JE, Farrimond JG, Browne RG, Sweny P, Moorhead JF. Prognosis of critically ill patients with acute renal failure: APACHE II score and other predictive factors. Q J Med 1989; 72: 857-866
13. Solez K, Morel-Maroger L, Sraer JD. The morphology of'acute tubular necrosis' in man: analysis of 57 renal biopsies and comparison with glycerol model. Medicine 1979; 58: 362-376
14. Linas SL, Whittenburg D, Parsons PE, Repine JE. Mild renal ischemia activates primed neutrophils to cause acute renal failure. Kidney Int 1992; 42: 610-616
15. Schulman G, Fogo A, Gung A, Badr K, Hakim R. Complement activation retards resolution of acute ischemic renal failure in the rat. Kidney Int 1991; 40: 1069-1074
16. Walton DF, Cheung AK. Membrane biocompatibility. In: Nissenson AR, Fine RN, Gentle DE, eds Clinical Dialysis third edition, Appleton & Lange, Connecticut. 1995: 93-120
17. Kränzlin B, Reuss A, Gretz N, Kirschfink M, Ryan CJ, Mujais SK. Recovery from ischemic acute renal failure: independence from dialysis membrane type. Nephron 1996; 73: 644-651
18. Neveu H, Kleinknecht D, Brivet F, Loirat Ph, Landais P, and The French Study Group on Acute Renal Failure. Prognostic factors in acute renal failure due to sepsis. Results of a prospective multicentre study. Nephrol Dial Transplant 1996; 11: 293-299
19. Shaldon S. Biocompatible membranes in acute renal failure: prospective case-controlled study. Nephrol Dial Transplant 1997; 12: 235-236
20. Mehta R, Farkas A, Pascual M, Fowler W. Effect of serial APACHE and organ failure scores on prediction of mortality. J Am Soc Nephrol 1995; 6: 550 [Abstract]
21. Jacobs C. Membrane biocompatibility in the treatment of acute renal failure: what is the evidence in 1996? Nephrol Dial Transplant 1997; 12: 38-42
22. Mujais SK, Ivanovich P, Vidovich MI. Dialysis in acute renal failure: which membrane? Arti Organs 1994; 18: 470-472
23. Simpson K, Allison MEM. Dialysis and acute renal failure: can mortality be improved? Nephrol Dial Transplant 1993; 8: 946 [Abstract]
24. Mehta R, McDonald B, Gabbai F, Pahl M, Farkas A, Pascual M, Fowler W and ARF Collaborative Study Group. Effect of biocompatible membranes on outcome of acute renal failure. J Am Soc Nephrol 1996; 7: 1457 [Abstract]
25. Assouad M, Tseng S, Dunn K, Gonzalez J, Brennan S, Suki W. Biocompatibility of dialyzer membrane is important in the outcome of acute renal failure. J Am Soc Nephrol 1996; 7: 1437 [Abstract]
26. Liano F, Pascual J, and the Madrid Acute Renal Failure Study Group. Epidemiology of acute renal failure: a prospective, multicenter, community-based study. Kidney Int 1996; 50: 811-818
27. Cosentino F, Chalf C, Piedmonte M. Risk factors influencing survival in ICU acute renal failure. Nephrol Dial Transplant 1994; 9 [Suppl. 4]: 179-182
28. Hakim RM, Held PJ, Stannard DC et al. Effect of the dialysis membrane on the mortality of chronic hemodialysis patients. Kidney Int 1996; 50: 566-570
29. Elsen R, Silva LK. Advantages of meltspun membrane technology compared to solution spinning. Contrib Nephrol 1993; 103: 125-138
30. Splendiani G, Mazzarella V. Artif Organs 1996; 20: 281
31. Gastaldello K, Melot JL, Vanherweghem JL, Kahn RJ, Tielemans C. Cellulose diacetale (CDA) does as well as polysulfone for the treatment of acute renal failure (ARF) in the intensive care unit (ICU). J Am Soc Nephrol 1996; 7: 1447 [Abstract]
32. Jörres A, Dobis C, Gahl GM et al. and the multicenter study group. Hemodialysis membrane biocompatibility does not impact on the mortality of patients with acute renal failure: a prospective randomized international multicenter trial. J Am Soc Nephrol 1998; 9: 212A 213A [Abstract]
33. Schiffl H, Lang S, Haider M. Biocompatibility of dialyzer membranes may have a negative impact on outcome of acute renal failure, independent of the dose of dialysis delivered. A retrospective multicenter analysis. ASAIO J 1998; 44: M418-M422